Search Results - "Azulay J-P"

Refine Results
  1. 1

    Brain FDG-PET correlates of saccadic disorders in early PSP by Pin, G., Labouré, J., Guedj, E., Felician, O., Grimaldi, S., Azulay, J. P., Ceccaldi, M., Koric, L.

    Published in Journal of neurology (01-10-2023)
    “…Background New diagnostic criteria of Progressive Supranuclear Palsy (PSP) have highlighted the interest of Eye Movement Records (EMR) at the early stage of…”
    Get full text
    Journal Article
  2. 2

    Orthostatic hypotension: Review and expert position statement by Vidal-Petiot, E., Pathak, A., Azulay, J.-P., Pavy-Le Traon, A., Hanon, O.

    Published in Revue neurologique (01-01-2024)
    “…Orthostatic hypotension is defined as a drop in systolic blood pressure of at least 20mmHg or a drop in diastolic blood pressure of at least 10mmHg within…”
    Get full text
    Journal Article
  3. 3

    Molecular imaging in Parkinsonism: The essential for clinical practice and future perspectives by Horowitz, T., Grimaldi, S., Azulay, J.-P., Guedj, E.

    Published in Revue neurologique (01-05-2022)
    “…Nuclear medicine with positron emission tomography (PET) and single photon emission computed tomography (SPECT) develops powerful tools in molecular imaging to…”
    Get full text
    Journal Article
  4. 4

    Postural disorders in Parkinson’s disease by Benatru, I, Vaugoyeau, M, Azulay, J.-P

    Published in Neurophysiologie clinique (01-12-2008)
    “…Summary Posture is often affected in Parkinson’s disease. Postural abnormalities belong to the motor axial involvement. Generally, postural dysfunction induces…”
    Get full text
    Journal Article
  5. 5

    Evaluation of a visual biofeedback on the postural control in Parkinson's disease by Caudron, S, Guerraz, M, Eusebio, A, Gros, J.-P, Azulay, J.-P, Vaugoyeau, M

    Published in Neurophysiologie clinique (01-01-2014)
    “…Summary Objectives Both stabilization and orientation components of postural control are affected in Parkinson's disease (PD). These deficits are partly due to…”
    Get full text
    Journal Article
  6. 6

    Nonmotor fluctuations in Parkinson's disease: Frequent and disabling by WITJAS, T, KAPHAN, E, AZULAY, J. P, BLIN, O, CECCALDI, M, POUGET, J, PONCET, M, ALI CHERIF, A

    Published in Neurology (13-08-2002)
    “…To assess the frequency and disability caused by nonmotor fluctuations (NMF) in PD. A structured questionnaire was administered to 50 patients with PD with…”
    Get full text
    Journal Article
  7. 7

    Multifocal motor neuropathy with and without conduction block : A single entity? by DELMONT, E, AZULAY, J. P, GIORGI, R, ATTARIAN, S, VERSCHUEREN, A, UZENOT, D, POUGET, J

    Published in Neurology (22-08-2006)
    “…To assess if multifocal motor neuropathy (MMN) with and MMN without conduction block (CB) are similar or distinct diseases. The authors reviewed the clinical…”
    Get full text
    Journal Article
  8. 8

    Impaired vertical postural control and proprioceptive integration deficits in Parkinson’s disease by Vaugoyeau, M, Viel, S, Assaiante, C, Amblard, B, Azulay, J.P

    Published in Neuroscience (11-05-2007)
    “…Abstract The aim of the present study was to investigate how the orientation and stabilization components of postural control may be affected as the result of…”
    Get full text
    Journal Article
  9. 9

    A randomized controlled double-blind study of rotigotine on neuropsychiatric symptoms in de novo PD by Castrioto, A., Thobois, S., Anheim, M., Quesada, J. L., Lhommée, E., Klinger, H., Bichon, A., Schmitt, E., Durif, F., Azulay, J. P., Houeto, J. L., Longato, N., Philipps, C., Pelissier, P., Broussolle, E., Moro, E., Tranchant, C., Fraix, V., Krack, P.

    Published in NPJ Parkinson's Disease (15-12-2020)
    “…Management of apathy, depression and anxiety in Parkinson’s disease (PD) represents a challenge. Dopamine agonists have been suggested to be effective. This…”
    Get full text
    Journal Article
  10. 10

    A combined pharmacokinetic/pharmacodynamic model of levodopa motor response and dyskinesia in Parkinson’s disease patients by Simon, N., Viallet, F., Boulamery, A., Eusebio, A., Gayraud, D., Azulay, J-P.

    Published in European journal of clinical pharmacology (01-04-2016)
    “…Purpose Levodopa is the reference treatment for Parkinson’s disease. However, after several years of treatment, dyskinesia may occur and strategies to overcome…”
    Get full text
    Journal Article
  11. 11

    Validation of a non-motor fluctuations questionnaire in Parkinson's disease by Faggianelli, F., Loundou, A., Baumstarck, K., Nathalie, S., Auquier, P., Eusebio, A., Defebvre, L., Brefel-Courbon, C., Houeto, J.-L., Maltete, D., Tranchant, C., Derkinderen, P., Geny, C., Krystkowiak, P., Jean-Philippe, B., Macia, F., Durif, F., Poujois, A., Borg, M., Azulay, J.-P., Witjas, T.

    Published in Revue neurologique (01-04-2022)
    “…•The longitudinal validation implied 255 patients among 15 centers in France.•Non-motor fluctuations statistically separated into three distinct…”
    Get full text
    Journal Article
  12. 12

    Prevalence and characterisation of vocal fold motion impairment (VFMI) in patients with Multiple system atrophy compared with Parkinson's disease by Grimaldi, S., Renaud, M., Robert, D., Lagier, A., Somma, H., Soulayrol, S., Korchia, D., Fluchère, F., Lagha-Boukbiza, O., Schaeffer, M., Witjas, T., Azulay, J.-P., Eusebio, A.

    Published in Revue neurologique (01-09-2020)
    “…•Laryngological examination may help discriminate PD from MSA.•VFMI, in particular VFAM, VFABD, BVFP should be discussed as possible MSA red flag.•BVFP was…”
    Get full text
    Journal Article Web Resource
  13. 13
  14. 14

    High insulinlike growth factor I is associated with cognitive decline in Huntington disease by Saleh, N, Moutereau, S, Azulay, J-P, Verny, C, Simonin, C, Tranchant, C, El Hawajri, N, Bachoud-Lévi, A-C, Maison, P

    Published in Neurology (06-07-2010)
    “…The somatotropic axis (growth hormone [GH] and insulinlike growth factor I [IGFI]) play a role in the cognitive deficits seen with aging, GH deficiency, and…”
    Get full text
    Journal Article
  15. 15

    News and controversies regarding essential tremor by Boutin, E., Vaugoyeau, M., Eusebio, A., Azulay, J.-P., Witjas, T.

    Published in Revue neurologique (01-05-2015)
    “…Essential tremor is the most common movement disorder in adults. It is characterized by a postural and kinetic tremor affecting the arms, but it can also…”
    Get full text
    Journal Article
  16. 16

    French consensus procedure for assessing cognitive function in Parkinson's disease by Dujardin, K., Auzou, N., Lhommée, E., Czernecki, V., Dubois, B., Fradet, A., Maltete, D., Meyer, M., Pineau, F., Schmitt, E., Sellal, F., Tison, F., Vidal, T., Azulay, J.-P., Welter, M.-L., Corvol, J.-C., Durif, F., Rascol, O.

    Published in Revue neurologique (01-11-2016)
    “…One of the objectives of the French expert centers for Parkinson's disease (NS-Park) network was to determine a consensus procedure for assessing cognitive…”
    Get full text
    Journal Article
  17. 17

    Progressive supranuclear palsy and corticobasal degeneration: Diagnostic challenges and clinicopathological considerations by Eusebio, A., Koric, L., Félician, O., Guedj, E., Ceccaldi, M., Azulay, J.-P.

    Published in Revue neurologique (01-08-2016)
    “…Progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) are two atypical parkinsonian syndromes first described half a century ago. The…”
    Get full text
    Journal Article
  18. 18

    Assessment of cortico-spinal tract impairment in multiple system atrophy using transcranial magnetic stimulation by Eusebio, A, Azulay, J.-P, Witjas, T, Rico, A, Attarian, S

    Published in Clinical neurophysiology (01-04-2007)
    “…Abstract Objective Among Parkinsonian syndromes, pyramidal signs suggesting cortico-spinal impairment are a hallmark of multiple system atrophy (MSA). Although…”
    Get full text
    Journal Article
  19. 19

    Chronic ataxic neuropathies associated with anti-GD1b IgM antibodies: response to IVIg therapy by Attarian, S, Boucraut, J, Hubert, A M, Uzenot, D, Delmont, E, Verschueren, A, Franques, J, Azulay, J P, Pouget, J

    “…Objective:To determine the responses to treatment of patients with chronic sensory ataxic neuropathy associated with anti-GD1b IgM antibodies.Methods:Patients…”
    Get full text
    Journal Article
  20. 20

    Motor activation in multiple system atrophy and Parkinson disease: A PET study by PAYOUX, P, BREFEL-COURBON, C, ESQUERRE, J. P, RASCOL, O, ORY-MAGNE, F, REGRAGUI, W, THALAMAS, C, BALDUYCK, S, DURIF, F, AZULAY, J. P, TISON, F, BLIN, O

    Published in Neurology (28-09-2010)
    “…Multiple system atrophy (MSA) is an atypical parkinsonian syndrome including cerebellar impairment and poor response to levodopa. We assessed right hand motor…”
    Get full text
    Journal Article